S433 200 mg Pill - gray green capsule/oblong, 20mm
Pill with imprint S433 200 mg is Gray / Green, Capsule/Oblong and has been identified as Carbamazepine Extended-Release 200 mg. It is supplied by Prasco Laboratories.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Bipolar Disorder; Schizoaffective Disorder; Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for S433 200 mg


Carbamazepine Extended-Release
- Imprint
- S433 200 mg
- Strength
- 200 mg
- Color
- Gray / Green
- Size
- 20.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Prasco Laboratories
- National Drug Code (NDC)
- 66993-0408
- Inactive Ingredients
-
citric acid monohydrate,
silicon dioxide,
lactose monohydrate,
microcrystalline cellulose,
sodium lauryl sulfate,
magnesium silicate,
triethyl citrate,
FD&C Red No. 3,
FD&C Yellow No. 6,
ferric oxide yellow,
FD&C Blue No. 2,
titanium dioxide,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
ammonio methacrylate copolymer type A
Note: Inactive ingredients may vary.
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (351)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Tegretol, Tegretol XR, Carbatrol, Epitol, ... +2 more
Professional resources
- Carbamazepine monograph
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
Other brands
Tegretol, Carbatrol, Epitol, Equetro, Carnexiv
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.